Fermented milk products like yogurt and cheese naturally produce ACE-inhibitory peptides during fermentation that survive digestion and have been shown to reduce blood pressure in animal and human studies.
Resistant to GI digestionMany ACE-inhibitory peptides from fermented milk survive stomach acid and digestive enzymes to reach their target in active form
What the researchers found
ACE-inhibitory peptides produced during milk fermentation are resistant to gastrointestinal digestion and can inhibit ACE in the renin-angiotensin system in their intact form. Their production and potency depend on multiple factors: the type of starter culture (lactic acid bacteria species, yeast), the milk protein substrate (casein type, whey protein), the specific peptide composition, and pre- and post-fermentation processing.
The antihypertensive effects of fermented milk products have been confirmed through in vitro studies, animal models, and human clinical trials. Several ACE-inhibitory peptides from fermented milk are now available in commercial products marketed for blood pressure support.
Why it matters
Hypertension affects over a billion people worldwide and is the leading risk factor for cardiovascular disease. While pharmaceutical ACE inhibitors are effective, they have side effects. Food-derived bioactive peptides offer a complementary approach — potentially preventing hypertension or reducing medication burden through everyday foods. Understanding what makes these peptides effective can guide the development of optimized functional dairy products.
How the study worked
Comprehensive narrative review of published literature on ACE-inhibitory peptides from fermented milk, covering peptide identification, production factors, gastrointestinal stability, and evidence from in vitro, animal, and human studies.
What this study cannot tell us
As a review, no new experimental data are presented. The blood pressure-lowering effects seen in clinical trials are generally modest compared to pharmaceutical ACE inhibitors. Bioavailability varies significantly between peptides and between individuals. Not all fermented milk products contain therapeutic concentrations of ACE-inhibitory peptides. The review does not comprehensively address dose-response relationships or long-term efficacy.
How to read the evidence
This is a narrative review summarizing evidence from multiple levels: in vitro ACE inhibition assays, animal models, and human clinical trials. While the breadth of evidence is strong, the review itself is not a systematic review or meta-analysis, and effect sizes in humans are generally modest.
When this study was published
Published in 2017, this review covers a well-established field. The fundamental science of milk-derived ACE-inhibitory peptides has not changed significantly since publication, though new starter cultures and processing methods continue to be explored.
The bigger picture
Food-derived bioactive peptides are one of the most mature areas of functional food research. ACE-inhibitory peptides from milk were among the first to be commercialized (notably in products like Calpis and Evolus), and they established the proof of concept that food peptides can have clinically meaningful physiological effects. This work has paved the way for the broader bioactive peptide field, including peptides from fish, soy, and other protein sources.
Questions still open
- Can fermented milk ACE-inhibitory peptides meaningfully reduce blood pressure in patients already on antihypertensive medication?
- Which specific lactic acid bacteria strains produce the most potent and bioavailable ACE-inhibitory peptides?
- Could these natural peptides serve as a preventive strategy for pre-hypertensive individuals to delay or avoid the need for medication?
Common questions
Can eating yogurt actually lower blood pressure?
How do these milk peptides survive being digested?
Read the original research
Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension.
Critical reviews in food science and nutrition, 57(13), 2789-2800
Citation
Rai, Amit Kumar; Sanjukta, Samurailatpam; Jeyaram, Kumaraswamy. (2017). Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension.. Critical reviews in food science and nutrition, 57(13), 2789-2800. https://doi.org/10.1080/10408398.2015.1068736